Journal article
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth
Abstract
BACKGROUND: Ketamine is an emerging treatment for treatment-resistant depression (TRD) associated with rapid and robust improvements in depressive symptoms and suicidality. However, the efficacy and safety of ketamine in transitional age youth (TAY; age 18-25) populations remains understudied.
METHODS: In this retrospective analysis, TAY patients (n = 52) receiving ketamine for TRD were matched for sex, primary diagnosis, baseline depression …
Authors
Chisamore N; Danayan K; Rodrigues NB; Di Vincenzo JD; Meshkat S; Doyle Z; Mansur R; Phan L; Fancy F; Chau E
Journal
Journal of Psychopharmacology, Vol. 37, No. 8, pp. 775–783
Publisher
SAGE Publications
Publication Date
August 2023
DOI
10.1177/02698811231171531
ISSN
0269-8811